Cite
HARVARD Citation
Lin, J. et al. (n.d.). An open label randomized phase II study of pasireotide with or without everolimus in castrate-resistant chemotherapy-naïve prostate cancer patients. Cancer treatment communications. pp. 192-195. [Online].